Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

NCT06545890 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2024-08-20

No results posted yet for this study

Summary

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.

Conditions

  • Emergence Delirium

Interventions

DRUG

Ketamine

continous infusion during surgery

DRUG

Dexmedetomidine

continous infusion during surgery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Karim K Fahim · Professor of Anesthesia, Pain management and Surgical ICU Faculty of Medicine, Cairo University.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-10
Primary Completion
2024-11-01
Completion
2024-11-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06545890 on ClinicalTrials.gov